HappyPoet wrote:Hi Harry,
Your comments over the years about the DMDs and the companies that make and market them always make me laugh. A new DMD just approved by the FDA (I forget its name) was originally used to FUMIGATE upholstered furniture! Yuck! How these companies can recycle such compounds into DMDs is beyond me.
Big pharma will take any compound, design some poorly designed studies, pay neuros grand sums to participate in trials, and then massage the data to show weak statistical significance with outcome measures that are barely higher than placebo. Finally, marketing will take over and start paying grand sums to prescribing neuros while charging ghastly sums to patients and insurance companies, BUT rarely, if ever, do the companies, themselves, perform long-term analysis of patients taking the DMDs.
Keep 'em coming, Harry!:)
Users browsing this forum: ElliotB